🟢 Vera Therapeutics is trading 7% up today as biotech stocks rally

Vera Therapeutics is trading at $34.27 (+7.00%), driven by biotech-sector strength.

• The XBI ETF is up 2.55%, supporting sector-wide gains, while the Nasdaq Composite is up 1.41%, improving risk appetite.
• Shares are rebounding after September 16’s 5.64% decline despite favorable TRUTAKNA Phase 3 results; prior weakness was described as profit-taking.
• ORIGIN 3 met all prespecified endpoints, with full FDA approval submission planned for Q4 2026.